Skip to main content

Table 1 Patient characteristics

From: The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma

  No. of patients (%)
Age (years)
 Median 50
 Range 15–84
Gender  
 Male 51 (51.5)
 Female 48 (48.5)
Any chronic comorbidity
 No 72 (72.7)
 Yes 27 (27.3)
Tumor site
 Lower extremity 73 (73.7)
 Upper extremity 26 (26.3)
Tumor size (cm)
  ≤ 5 34 (34.3)
  > 5 61 (61.6)
 Unknowna 4 (4.0)
Tumor depth
 Superficial 30 (30.3)
 Deep 69 (69.7)
FNCLCC grade
 1 17 (17.2)
 2 50 (50.5)
 3 32 (32.3)
Histological subtype
 MFH 35 (35.4)
 Myxoid liposarcoma 26 (26.3)
 Synovial sarcoma 10 (10.1)
 Dedifferentiated liposarcoma 8 (8.1)
 Myxofibrosarcoma 5 (5.1)
 Fibrosarcoma 5 (5.1)
 MPNST 5 (5.1)
 Ewing sarcoma/ PNET 5 (5.1)
Resection margin
 Negative 77 (77.8)
 Close (≤2 mm) 9 (9.1)
 Positive 10 (10.1)
 Unknowna 3 (3.0)
Treatment modality
 Surgery + RT 58 (58.6)
 Surgery + RT + CXT 41 (41.4)
RT dose (Gy)
 Median 60
 Range 46–66
  1. Abbreviations: FNCLCC Fédération Nationale des Centres de Lutte Contre le Cancer, MFH malignant fibrous histiocytoma, MPNST malignant peripheral nerve sheath tumor, PNET primitive neuroectodermal tumor, RT radiotherapy, CXT chemotherapy
  2. aIt was not possible to evaluate in patients who underwent excision at an outside institution